Cargando…
Fundus autofluorescence imaging using red excitation light
Retinal disease accounts significantly for visual impairment and blindness. An important role in the pathophysiology of retinal disease and aging is attributed to lipofuscin, a complex of fluorescent metabolites. Fundus autofluorescence (AF) imaging allows non-invasive mapping of lipofuscin and is a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279676/ https://www.ncbi.nlm.nih.gov/pubmed/37336979 http://dx.doi.org/10.1038/s41598-023-36217-x |
_version_ | 1785060637985996800 |
---|---|
author | Birtel, Johannes Bauer, Tobias Pauleikhoff, Laurenz Rüber, Theodor Gliem, Martin Charbel Issa, Peter |
author_facet | Birtel, Johannes Bauer, Tobias Pauleikhoff, Laurenz Rüber, Theodor Gliem, Martin Charbel Issa, Peter |
author_sort | Birtel, Johannes |
collection | PubMed |
description | Retinal disease accounts significantly for visual impairment and blindness. An important role in the pathophysiology of retinal disease and aging is attributed to lipofuscin, a complex of fluorescent metabolites. Fundus autofluorescence (AF) imaging allows non-invasive mapping of lipofuscin and is a key technology to diagnose and monitor retinal disease. However, currently used short-wavelength (SW) excitation light has several limitations, including glare and discomfort during image acquisition, reduced image quality in case of lens opacities, limited visualization of the central retina, and potential retinal light toxicity. Here, we establish a novel imaging modality which uses red excitation light (R-AF) and overcomes these drawbacks. R-AF images are high-quality, high-contrast fundus images and image interpretation may build on clinical experience due to similar appearance of pathology as on SW-AF images. Additionally, R-AF images may uncover disease features that previously remained undetected. The R-AF signal increases with higher abundance of lipofuscin and does not depend on photopigment bleaching or on the amount of macular pigment. Improved patient comfort, limited effect of cataract on image quality, and lack of safety concerns qualify R-AF for routine clinical monitoring, e.g. for patients with age-related macular degeneration, Stargardt disease, or for quantitative analysis of AF signal intensity. |
format | Online Article Text |
id | pubmed-10279676 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-102796762023-06-21 Fundus autofluorescence imaging using red excitation light Birtel, Johannes Bauer, Tobias Pauleikhoff, Laurenz Rüber, Theodor Gliem, Martin Charbel Issa, Peter Sci Rep Article Retinal disease accounts significantly for visual impairment and blindness. An important role in the pathophysiology of retinal disease and aging is attributed to lipofuscin, a complex of fluorescent metabolites. Fundus autofluorescence (AF) imaging allows non-invasive mapping of lipofuscin and is a key technology to diagnose and monitor retinal disease. However, currently used short-wavelength (SW) excitation light has several limitations, including glare and discomfort during image acquisition, reduced image quality in case of lens opacities, limited visualization of the central retina, and potential retinal light toxicity. Here, we establish a novel imaging modality which uses red excitation light (R-AF) and overcomes these drawbacks. R-AF images are high-quality, high-contrast fundus images and image interpretation may build on clinical experience due to similar appearance of pathology as on SW-AF images. Additionally, R-AF images may uncover disease features that previously remained undetected. The R-AF signal increases with higher abundance of lipofuscin and does not depend on photopigment bleaching or on the amount of macular pigment. Improved patient comfort, limited effect of cataract on image quality, and lack of safety concerns qualify R-AF for routine clinical monitoring, e.g. for patients with age-related macular degeneration, Stargardt disease, or for quantitative analysis of AF signal intensity. Nature Publishing Group UK 2023-06-19 /pmc/articles/PMC10279676/ /pubmed/37336979 http://dx.doi.org/10.1038/s41598-023-36217-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Birtel, Johannes Bauer, Tobias Pauleikhoff, Laurenz Rüber, Theodor Gliem, Martin Charbel Issa, Peter Fundus autofluorescence imaging using red excitation light |
title | Fundus autofluorescence imaging using red excitation light |
title_full | Fundus autofluorescence imaging using red excitation light |
title_fullStr | Fundus autofluorescence imaging using red excitation light |
title_full_unstemmed | Fundus autofluorescence imaging using red excitation light |
title_short | Fundus autofluorescence imaging using red excitation light |
title_sort | fundus autofluorescence imaging using red excitation light |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279676/ https://www.ncbi.nlm.nih.gov/pubmed/37336979 http://dx.doi.org/10.1038/s41598-023-36217-x |
work_keys_str_mv | AT birteljohannes fundusautofluorescenceimagingusingredexcitationlight AT bauertobias fundusautofluorescenceimagingusingredexcitationlight AT pauleikhofflaurenz fundusautofluorescenceimagingusingredexcitationlight AT rubertheodor fundusautofluorescenceimagingusingredexcitationlight AT gliemmartin fundusautofluorescenceimagingusingredexcitationlight AT charbelissapeter fundusautofluorescenceimagingusingredexcitationlight |